Low Molecular Weight Hyaluronan Induces Malignant Mesothelioma Cell (MMC) Proliferation and Haptotaxis: Role of CD44 Receptor in MMC Proliferation and Haptotaxis

Oncology Research

Volumn 13, Issue 2, 2002, Pages 71-78

  Nasreen, Najmunnisa ^a   Mohammed, Kamal A ^a   Hardwick, Joyce ^a   Van Horn, Robert D ^a   Sanders, Kerry ^a   Kathuria, Hasmeena ^a   Loghmani, Farzad ^a   Antony, Veena B ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CD44 receptor; Haptotaxis; Hyaluronan; Malignant mesothelioma; Proliferation

Indexed keywords

CD44 RECEPTOR; CELL SURFACE RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; GLYCOSAMINOGLYCAN; HIGH MOLECULAR WEIGHT HYALURONIC ACID; HYALURONIC ACID; HYALURONIC ACID RECEPTOR; LOW MOLECULAR WEIGHT HYALURONIC ACID; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; HERMES ANTIGEN; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; MOLECULAR WEIGHT; NORTHERN BLOTTING; PLEURA CAVITY; PRIORITY JOURNAL; TUMOR GROWTH; CELL CULTURE; CELL DIVISION; CELL MOTION; DRUG EFFECT; GENETICS; MESOTHELIOMA; PATHOLOGY; PHYSIOLOGY;

ANTIGENS, CD44; CELL DIVISION; CELL MOVEMENT; HUMANS; HYALURONIC ACID; MESOTHELIOMA; MOLECULAR WEIGHT; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036363322     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Elmes, P. C.; Simpson, J. C. The clinical aspects of mesothelioma. Q. J. Med. 45:427-449; 1976.
2. Pettersson, T.; Froseth, B.; Riska, H.; Klockars, M. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 94:1037-1039; 1988.
3. Atagi, S.; Ogawara, M.; Kawahara, M.; Sakatani, M.; Furuse, K.; Ueda, E. ; Yamamoto, S. Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: Likelihood ratios for malignant mesothelioma. Jpn. J. Clin. Oncol. 27:293-297; 1997.
4. Shannon, B. T.; Love, S. H.; Myrvik, Q. N. Participation of hyaluronic acid in the macrophage disappearance reaction. Immunol. Commun. 9:357-370; 1980.
5. Underhill, C.; Dorfman, A. The role of hyaluronic acid in intercellular adhesion of cultured mouse cells. Exp. Cell Res. 117:155-164; 1978.
6. Toole, B. Glycosaminoglycans in morphogenesis. In: Hay, E., ed. Cell biology of the extracellular matrix. New York: Plenum Press; 1981:259-294.
7. Ahlgren, T.; Jarstrand, C. Hyaluronic acid enhances phagocytosis of human monocytes in vitro. J. Clin. Immunol. 4:246-249; 1984.
8. Hakansson, L.; Hallgren, R.; Venge, P. Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J. Clin. Invest. 66:298-305; 1980.
9. Yeo, T. K.; Nagy, J. A.; Yeo, K. T.; Dvorak, H. F.; Toole, B. P. Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells. Am. J. Pathol. 148:1733-1740; 1996.
10. Asplund, T.; Heldin, P. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. Cancer Res. 54:4516-4523; 1994.
11. Naot, D.; Sionov, R. V.; Ish-Shalom, D. CD44: Structure, function, and association with the malignant process. Adv. Cancer Res. 71:241-319; 1997.
12. Horst, E.; Meijer, C. J.; Radaszkiewicz, T.; Ossekoppele, G. J.; Van Krieken, J. H.; Pals, S. T. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 4:595-599; 1990.
13. Thomas, L.; Byers, H. R.; Vink, J.; Stamenkovic, I. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118: 971-977; 1992.
14. Lokeshwar, B. L.; Lokeshwar, V. B.; Block, N. L. Expression of CD44 in prostate cancer cells: Association with cell proliferation and invasive potential. Anticancer Res. 15:1191-1198; 1995.
15. Jackson, P. A.; Green, M. A.; Pouli, A.; Hubbard, R.; Marks, C. G.; Cook, M. G. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum. J. Clin. Pathol. 48: 1098-101; 1995.
16. Tanabe, K. K.; Stamenkovic, I.; Cutler, M.; Takahashi, K. Restoration of CD44H expression in colon carcinomas reduces tumorigenicity. Ann. Surg. 222:493-503; 1995.
17. Lauber, B.; Leuthold, M.; Schmitter, D.; Cano-Santos, J.; Waibel, R.; Stahel, R. A. An autocrine mitogenic activity produced by a pleural human mesothelioma cell line. Int. J. Cancer 50:943-950; 1992.
18. Nasreen, N.; Hartman, D. L.; Mohammed, K. A.; Antony, V. B. Talc-induced expression of C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells. Am. J. Respir. Crit. Care Med. 158:971-978; 1998.
19. Mohammed, K. A.; Nasreen, N.; Ward, M. J.; Antony, V. B. Macrophage inflammatory protein-lalpha C-C chemokine in parapneumonic pleural effusions. J. Lab. Clin. Med. 132:202-209; 1998.
20. Nasreen, N.; Mohammed, K. A.; Galffy, G.; Ward, M. J.; Antony, V. B. MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 278: L591-598; 2000.
21. Nehls, V.; Hayen, W. Are hyaluronan receptors involved in three-dimensional cell migration? Histol. Histopathol. 15:629-636; 2000.
22. Underhill, C. CD44: The hyaluronan receptor. J. Cell Sci. 103:293-298; 1992.
23. Turley, E. A.; Tretiak, M. Glycosaminoglycan production by murine melanoma variants in vivo and in vitro. Cancer Res. 45:5098-5105; 1985.
24. Thomas, L.; Etoh, T.; Stamenkovic, I.; Mihm, M. C., Jr.; Byers, H. R. Migration of human melanoma cells on hyaluronate is related to CD44 expression. J. Invest. Dermatol. 100:115-120; 1993.
25. Culty, M.; Nguyen, H. A.; Underhill, C. B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116:1055-1062; 1992.
26. Knudson, W.; Biswas, C.; Li, X. Q.; Nemec, R. E.; Toole, B. P. The role and regulation of tumour-associated hyaluronan. Ciba Found. Symp. 143:150-159; 1989.
27. Stamenkovic, I.; Amiot, M.; Pesando, J. M.; Seed, B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56:1057-1062; 1989.
28. Kuppner, M. C.; Van Meir, E.; Gauthier, T.; Hamou, M. F.; de Tribolet, N. Differential expression of the CD44 molecule in human brain tumours. Int. J. Cancer 50:572-577; 1992.
29. Gunthert, U.; Hofmann, M.; Rudy, W.; Reber, S.; Zoller, M.; Haussmann, I.; Matzku, S.; Wenzel, A.; Ponta, H.; Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24; 1991.
30. Bartolazzi, A.; Peach, R.; Aruffo, A.; Stamenkovic, I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180:53-66; 1994.
31. Pure, E.; Camp, R. L.; Peritt, D.; Panettieri, R. A., Jr.; Lazaar, A. L. ; Nayak, S. Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 181:55-62; 1995.
32. Trochon, V.; Mabilat-Pragnon, C.; Bertrand, P.; Legrand, Y.; Soria, J.; Soria, C.; Delpech, B.; Lu, H. Hyaluronectin blocks the stimulatory effect of hyaluronan-derived fragments on endothelial cells during angiogenesis in vitro. FEBS Lett. 418:6-10; 1997.
33. Bjermer, L.; Lundgren, R.; Hallgren, R. Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax 44:126; 1989.
34. Lees, V. C.; Fan, T. P. D.; West, D. C. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab. Invest. 73:259-266; 1995.
35. Trochon, V.; Mabilat, C.; Bertrand, P.; Legrand, Y.; Smadja-Joffe, F.; Soria, C.; Delpech, B.; Lu, H. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int. J. Cancer 66:664-668; 1996.